

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.41678000 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.41678000 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 6.12928091 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 6.12928091 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.85612501 |
| 6 | signal peptide processing (GO:0006465) | 5.73160829 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.66953742 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.66953742 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.59662553 |
| 10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.52899903 |
| 11 | neutrophil activation (GO:0042119) | 4.35510722 |
| 12 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.29216913 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.22561869 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.14991603 |
| 15 | regulation of mast cell degranulation (GO:0043304) | 4.11364304 |
| 16 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.10635013 |
| 17 | peptide hormone processing (GO:0016486) | 4.05093137 |
| 18 | protein maturation by protein folding (GO:0022417) | 4.04987652 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.04552142 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.04552142 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.04552142 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.04552142 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.04552142 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.04552142 |
| 25 | mast cell activation (GO:0045576) | 3.98118494 |
| 26 | detection of other organism (GO:0098543) | 3.97975686 |
| 27 | detection of bacterium (GO:0016045) | 3.96215728 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.95614738 |
| 29 | endocrine pancreas development (GO:0031018) | 3.93857812 |
| 30 | polyketide metabolic process (GO:0030638) | 3.88657111 |
| 31 | doxorubicin metabolic process (GO:0044598) | 3.88657111 |
| 32 | daunorubicin metabolic process (GO:0044597) | 3.88657111 |
| 33 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.87623837 |
| 34 | regulation of B cell differentiation (GO:0045577) | 3.86695474 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 3.84890215 |
| 36 | response to peptidoglycan (GO:0032494) | 3.83558722 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.83512122 |
| 38 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.83357525 |
| 39 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.80683053 |
| 40 | granulocyte activation (GO:0036230) | 3.78724554 |
| 41 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.78670472 |
| 42 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.76081147 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.66166226 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.65864102 |
| 45 | cellular extravasation (GO:0045123) | 3.63622112 |
| 46 | regulation of mast cell activation (GO:0033003) | 3.61475633 |
| 47 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.61048209 |
| 48 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.57269796 |
| 49 | thrombin receptor signaling pathway (GO:0070493) | 3.57264747 |
| 50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.55473172 |
| 51 | sequestering of metal ion (GO:0051238) | 3.54957421 |
| 52 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.52676738 |
| 53 | positive regulation of insulin secretion (GO:0032024) | 3.46297741 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.46074418 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.44424281 |
| 56 | regulation of platelet aggregation (GO:0090330) | 3.41458710 |
| 57 | ribosomal small subunit assembly (GO:0000028) | 3.41319272 |
| 58 | megakaryocyte development (GO:0035855) | 3.40094672 |
| 59 | mast cell degranulation (GO:0043303) | 3.39073572 |
| 60 | mast cell activation involved in immune response (GO:0002279) | 3.39073572 |
| 61 | interferon-gamma production (GO:0032609) | 3.37052073 |
| 62 | response to muramyl dipeptide (GO:0032495) | 3.36728603 |
| 63 | endosome to melanosome transport (GO:0035646) | 3.35796440 |
| 64 | endosome to pigment granule transport (GO:0043485) | 3.35796440 |
| 65 | B cell mediated immunity (GO:0019724) | 3.32589774 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32065181 |
| 67 | DNA deamination (GO:0045006) | 3.31778382 |
| 68 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.28734628 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.28734628 |
| 70 | definitive hemopoiesis (GO:0060216) | 3.28304281 |
| 71 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.26688115 |
| 72 | positive regulation of mast cell degranulation (GO:0043306) | 3.26688115 |
| 73 | microglial cell activation (GO:0001774) | 3.26194822 |
| 74 | macrophage activation involved in immune response (GO:0002281) | 3.23872250 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.18246154 |
| 76 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.16612282 |
| 77 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.16612282 |
| 78 | protein autoprocessing (GO:0016540) | 3.16571801 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 3.15817139 |
| 80 | response to host immune response (GO:0052572) | 3.15334714 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.15334714 |
| 82 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.12544309 |
| 83 | type B pancreatic cell development (GO:0003323) | 3.11414840 |
| 84 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.10797713 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10046155 |
| 86 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.09619407 |
| 87 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.08725751 |
| 88 | germinal center formation (GO:0002467) | 3.08709072 |
| 89 | GDP-mannose metabolic process (GO:0019673) | 3.07866180 |
| 90 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.07710598 |
| 91 | detection of external biotic stimulus (GO:0098581) | 3.05640133 |
| 92 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.04243139 |
| 93 | Peyers patch development (GO:0048541) | 3.04243139 |
| 94 | cotranslational protein targeting to membrane (GO:0006613) | 3.04038823 |
| 95 | negative regulation of phagocytosis (GO:0050765) | 3.02611650 |
| 96 | tolerance induction (GO:0002507) | 3.02468907 |
| 97 | regulation of gamma-delta T cell activation (GO:0046643) | 3.02133471 |
| 98 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.01227174 |
| 99 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.00602952 |
| 100 | respiratory burst (GO:0045730) | 3.00400289 |
| 101 | positive T cell selection (GO:0043368) | 3.00008866 |
| 102 | protein targeting to ER (GO:0045047) | 2.99746679 |
| 103 | platelet dense granule organization (GO:0060155) | 2.99084641 |
| 104 | glandular epithelial cell differentiation (GO:0002067) | 2.96592021 |
| 105 | glycoside metabolic process (GO:0016137) | 2.96205879 |
| 106 | T cell selection (GO:0045058) | 2.93200681 |
| 107 | regulation of regulated secretory pathway (GO:1903305) | 2.93183005 |
| 108 | negative regulation of innate immune response (GO:0045824) | 2.93058870 |
| 109 | leukocyte degranulation (GO:0043299) | 2.91340460 |
| 110 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.90379077 |
| 111 | protein localization to endoplasmic reticulum (GO:0070972) | 2.89886329 |
| 112 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.89710172 |
| 113 | T cell homeostasis (GO:0043029) | 2.88790391 |
| 114 | negative regulation of bone resorption (GO:0045779) | 2.87773353 |
| 115 | regulation of granulocyte differentiation (GO:0030852) | 2.87340251 |
| 116 | COPII vesicle coating (GO:0048208) | 2.86640844 |
| 117 | defense response to protozoan (GO:0042832) | 2.85536699 |
| 118 | glandular epithelial cell development (GO:0002068) | 2.85500677 |
| 119 | negative regulation of interleukin-6 production (GO:0032715) | 2.84969771 |
| 120 | thymic T cell selection (GO:0045061) | 2.84861884 |
| 121 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83678968 |
| 122 | response to host (GO:0075136) | 2.83678968 |
| 123 | response to host defenses (GO:0052200) | 2.83678968 |
| 124 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.83641460 |
| 125 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.82801532 |
| 126 | protein retention in ER lumen (GO:0006621) | 2.82781607 |
| 127 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.82176953 |
| 128 | mannosylation (GO:0097502) | 2.81079589 |
| 129 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78434316 |
| 130 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.78000171 |
| 131 | activated T cell proliferation (GO:0050798) | 2.77036805 |
| 132 | fucose metabolic process (GO:0006004) | 2.76494207 |
| 133 | nucleoside diphosphate catabolic process (GO:0009134) | 2.75822151 |
| 134 | positive regulation of B cell differentiation (GO:0045579) | 2.73899088 |
| 135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72780927 |
| 136 | positive regulation of peptide hormone secretion (GO:0090277) | 2.71810317 |
| 137 | T cell migration (GO:0072678) | 2.71250455 |
| 138 | macrophage activation (GO:0042116) | 2.71188866 |
| 139 | detection of biotic stimulus (GO:0009595) | 2.71185618 |
| 140 | response to interleukin-15 (GO:0070672) | 2.69655983 |
| 141 | leukocyte aggregation (GO:0070486) | 2.69326871 |
| 142 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.68610636 |
| 143 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.68291167 |
| 144 | astrocyte differentiation (GO:0048708) | 2.67428025 |
| 145 | lymph node development (GO:0048535) | 2.65457680 |
| 146 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.63803841 |
| 147 | positive regulation of peptide secretion (GO:0002793) | 2.60889282 |
| 148 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.60431173 |
| 149 | regulation of oxidative phosphorylation (GO:0002082) | 2.59120559 |
| 150 | insulin secretion (GO:0030073) | 2.58509884 |
| 151 | cellular response to interleukin-15 (GO:0071350) | 2.57155046 |
| 152 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.56769917 |
| 153 | natural killer cell activation involved in immune response (GO:0002323) | 2.56377167 |
| 154 | positive thymic T cell selection (GO:0045059) | 2.54685254 |
| 155 | regulation of insulin secretion (GO:0050796) | 2.54397959 |
| 156 | amyloid precursor protein metabolic process (GO:0042982) | 2.51822875 |
| 157 | respiratory chain complex IV assembly (GO:0008535) | 2.49323613 |
| 158 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48971178 |
| 159 | regulation of defense response to virus by virus (GO:0050690) | 2.47978492 |
| 160 | GPI anchor biosynthetic process (GO:0006506) | 2.47341089 |
| 161 | amyloid precursor protein catabolic process (GO:0042987) | 2.47264439 |
| 162 | negative T cell selection (GO:0043383) | 2.45430385 |
| 163 | positive regulation of granulocyte differentiation (GO:0030854) | 2.44302373 |
| 164 | lysosome localization (GO:0032418) | 2.44252366 |
| 165 | viral protein processing (GO:0019082) | 2.43682005 |
| 166 | lymphoid progenitor cell differentiation (GO:0002320) | 2.42631741 |
| 167 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.42276423 |
| 168 | toxin transport (GO:1901998) | 2.39942330 |
| 169 | negative thymic T cell selection (GO:0045060) | 2.37811524 |
| 170 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.37615566 |
| 171 | regulation of regulatory T cell differentiation (GO:0045589) | 2.36818341 |
| 172 | regulation of axon regeneration (GO:0048679) | 2.36494396 |
| 173 | regulation of neuron projection regeneration (GO:0070570) | 2.36494396 |
| 174 | regulation of erythrocyte differentiation (GO:0045646) | 2.36354840 |
| 175 | regulation of peptide hormone secretion (GO:0090276) | 2.35121414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.94748997 |
| 2 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.92424122 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.67136450 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53219758 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.48031415 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.43490112 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.39855981 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.38571809 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.33283105 |
| 10 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.10901948 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.01904401 |
| 12 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.87886975 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.80030840 |
| 14 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.65585192 |
| 15 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64517537 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53910209 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.53408521 |
| 18 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50721479 |
| 19 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.49450406 |
| 20 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.43952284 |
| 21 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34087218 |
| 22 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.33306676 |
| 23 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.26921570 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.24592214 |
| 25 | * MYB_26560356_Chip-Seq_TH2_Human | 2.11806888 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.10114150 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.09187299 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.07908121 |
| 29 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.07392014 |
| 30 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 2.05641434 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.01257715 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.99660939 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97246658 |
| 34 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96364522 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.94156552 |
| 36 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.91587327 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88207965 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.88195764 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.85372977 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79500187 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.78288035 |
| 42 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77179101 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.74427960 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.72757850 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72519423 |
| 46 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.71530325 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67152465 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66690891 |
| 49 | * MYB_26560356_Chip-Seq_TH1_Human | 1.65619579 |
| 50 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.64890607 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60071184 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59609941 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56532185 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52035480 |
| 55 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48347003 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47639046 |
| 57 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47592055 |
| 58 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.47530695 |
| 59 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47510288 |
| 60 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47488574 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46106667 |
| 62 | GATA2_19941826_ChIP-Seq_K562_Human | 1.45779805 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44317283 |
| 64 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43677580 |
| 65 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.43355043 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42405578 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39691901 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39606788 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39301551 |
| 70 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.38883154 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33947684 |
| 72 | * MAF_26560356_Chip-Seq_TH1_Human | 1.32669566 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30988988 |
| 74 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.30877307 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30610073 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.30392786 |
| 77 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28877918 |
| 78 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28253278 |
| 79 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.27370836 |
| 80 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.24823164 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23058297 |
| 82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.22419603 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21808775 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20881115 |
| 85 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20481929 |
| 86 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.20008265 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19721940 |
| 88 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.19356663 |
| 89 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17806128 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16280416 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15546794 |
| 92 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.14823818 |
| 93 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13858528 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12784231 |
| 95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.12669020 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12358595 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10755533 |
| 98 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09849267 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09264219 |
| 100 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08314395 |
| 101 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08269458 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03197320 |
| 103 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02568093 |
| 104 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02286911 |
| 105 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01917679 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01895853 |
| 107 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00931640 |
| 108 | P300_27268052_Chip-Seq_Bcells_Human | 1.00507051 |
| 109 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98583833 |
| 110 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97869051 |
| 111 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95869307 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95022262 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93257891 |
| 114 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92222667 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91450097 |
| 116 | MAF_26560356_Chip-Seq_TH2_Human | 0.91025305 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90747522 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90154421 |
| 119 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89699483 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.89275069 |
| 121 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88526607 |
| 122 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.88125902 |
| 123 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87352920 |
| 124 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86774752 |
| 125 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85512880 |
| 126 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83945238 |
| 127 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.83617719 |
| 128 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.83370791 |
| 129 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83217191 |
| 130 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.82721840 |
| 131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82167843 |
| 132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79500412 |
| 133 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.78066014 |
| 134 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77910741 |
| 135 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.76952181 |
| 136 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.75915669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 3.68214217 |
| 2 | MP0003303_peritoneal_inflammation | 3.49037821 |
| 3 | MP0005379_endocrine/exocrine_gland_phen | 3.37175380 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.15942525 |
| 5 | MP0001986_abnormal_taste_sensitivity | 3.15040873 |
| 6 | MP0005671_abnormal_response_to | 3.07406518 |
| 7 | MP0002693_abnormal_pancreas_physiology | 2.94520737 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.85723744 |
| 9 | MP0000013_abnormal_adipose_tissue | 2.71217257 |
| 10 | MP0005645_abnormal_hypothalamus_physiol | 2.42940749 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.42715898 |
| 12 | MP0001944_abnormal_pancreas_morphology | 2.37987743 |
| 13 | MP0003724_increased_susceptibility_to | 2.23934390 |
| 14 | MP0003866_abnormal_defecation | 2.20526934 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.18873655 |
| 16 | MP0000685_abnormal_immune_system | 2.15104667 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.15028518 |
| 18 | MP0004043_abnormal_pH_regulation | 2.09247628 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.08338340 |
| 20 | MP0005174_abnormal_tail_pigmentation | 2.04245788 |
| 21 | MP0009278_abnormal_bone_marrow | 1.99970915 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.99288731 |
| 23 | MP0002396_abnormal_hematopoietic_system | 1.92043660 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.90417365 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.88521343 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.86817113 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.84736990 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.82899486 |
| 29 | MP0005387_immune_system_phenotype | 1.80648749 |
| 30 | MP0001790_abnormal_immune_system | 1.80648749 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.80477451 |
| 32 | MP0000678_abnormal_parathyroid_gland | 1.78898464 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.78534016 |
| 34 | MP0002723_abnormal_immune_serum | 1.78192941 |
| 35 | MP0002398_abnormal_bone_marrow | 1.77765659 |
| 36 | MP0001819_abnormal_immune_cell | 1.74921470 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.74165030 |
| 38 | MP0003828_pulmonary_edema | 1.72281785 |
| 39 | MP0009785_altered_susceptibility_to | 1.71286663 |
| 40 | MP0008004_abnormal_stomach_pH | 1.70317876 |
| 41 | MP0001800_abnormal_humoral_immune | 1.69206026 |
| 42 | MP0001851_eye_inflammation | 1.69183640 |
| 43 | MP0002163_abnormal_gland_morphology | 1.65012297 |
| 44 | MP0002638_abnormal_pupillary_reflex | 1.63834249 |
| 45 | MP0003195_calcinosis | 1.60058739 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.59417791 |
| 47 | MP0005025_abnormal_response_to | 1.57959792 |
| 48 | MP0000716_abnormal_immune_system | 1.53221983 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.50628069 |
| 50 | MP0009764_decreased_sensitivity_to | 1.50333403 |
| 51 | MP0002095_abnormal_skin_pigmentation | 1.49385408 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.44893842 |
| 53 | MP0005310_abnormal_salivary_gland | 1.42793225 |
| 54 | MP0003283_abnormal_digestive_organ | 1.40106794 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.38576276 |
| 56 | MP0001188_hyperpigmentation | 1.36073814 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.36000411 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.31893625 |
| 59 | MP0002429_abnormal_blood_cell | 1.30566333 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.30063972 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.29998493 |
| 62 | MP0002419_abnormal_innate_immunity | 1.29412183 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.29283977 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 1.29034641 |
| 65 | MP0001765_abnormal_ion_homeostasis | 1.26037508 |
| 66 | MP0002722_abnormal_immune_system | 1.25489695 |
| 67 | MP0002928_abnormal_bile_duct | 1.24007020 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.21290422 |
| 69 | MP0004381_abnormal_hair_follicle | 1.18961774 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 1.18711761 |
| 71 | MP0004147_increased_porphyrin_level | 1.16158574 |
| 72 | MP0002405_respiratory_system_inflammati | 1.13861519 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.13849662 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.10870925 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.10004227 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.10004227 |
| 77 | MP0002166_altered_tumor_susceptibility | 1.09750252 |
| 78 | MP0003075_altered_response_to | 1.08143225 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.07291328 |
| 80 | MP0003959_abnormal_lean_body | 1.06763793 |
| 81 | MP0006054_spinal_hemorrhage | 1.06226637 |
| 82 | MP0008260_abnormal_autophagy | 1.04786857 |
| 83 | MP0009763_increased_sensitivity_to | 1.04776721 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 1.04687652 |
| 85 | MP0000858_altered_metastatic_potential | 1.04168533 |
| 86 | MP0001873_stomach_inflammation | 1.03684363 |
| 87 | MP0000372_irregular_coat_pigmentation | 1.02414674 |
| 88 | MP0002938_white_spotting | 1.01925846 |
| 89 | MP0002933_joint_inflammation | 1.01647115 |
| 90 | MP0003868_abnormal_feces_composition | 1.01222785 |
| 91 | MP0006072_abnormal_retinal_apoptosis | 1.00898989 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 1.00113374 |
| 93 | MP0003436_decreased_susceptibility_to | 0.98667677 |
| 94 | MP0001663_abnormal_digestive_system | 0.98552846 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.97770648 |
| 96 | MP0001502_abnormal_circadian_rhythm | 0.97506583 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.94625069 |
| 98 | MP0000613_abnormal_salivary_gland | 0.94234203 |
| 99 | MP0006082_CNS_inflammation | 0.91561254 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.90725767 |
| 101 | MP0000343_altered_response_to | 0.90170037 |
| 102 | MP0005409_darkened_coat_color | 0.89883361 |
| 103 | MP0000490_abnormal_crypts_of | 0.89838552 |
| 104 | MP0009780_abnormal_chondrocyte_physiolo | 0.88292137 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.85249368 |
| 106 | MP0003943_abnormal_hepatobiliary_system | 0.84598495 |
| 107 | MP0004510_myositis | 0.83685972 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.83230579 |
| 109 | MP0004130_abnormal_muscle_cell | 0.83210641 |
| 110 | MP0008469_abnormal_protein_level | 0.82134595 |
| 111 | MP0004883_abnormal_blood_vessel | 0.82046039 |
| 112 | MP0005084_abnormal_gallbladder_morpholo | 0.82037961 |
| 113 | MP0005083_abnormal_biliary_tract | 0.81923555 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.78923365 |
| 115 | MP0002132_abnormal_respiratory_system | 0.77825051 |
| 116 | MP0004947_skin_inflammation | 0.77544298 |
| 117 | MP0003122_maternal_imprinting | 0.77410244 |
| 118 | MP0005390_skeleton_phenotype | 0.76782014 |
| 119 | MP0002019_abnormal_tumor_incidence | 0.76457832 |
| 120 | MP0003953_abnormal_hormone_level | 0.76402969 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.76267307 |
| 122 | MP0000249_abnormal_blood_vessel | 0.74667399 |
| 123 | MP0003252_abnormal_bile_duct | 0.74423624 |
| 124 | MP0005166_decreased_susceptibility_to | 0.73654664 |
| 125 | MP0003806_abnormal_nucleotide_metabolis | 0.72838061 |
| 126 | MP0003879_abnormal_hair_cell | 0.72460702 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.69440687 |
| 128 | MP0001270_distended_abdomen | 0.69225633 |
| 129 | MP0008874_decreased_physiological_sensi | 0.68996027 |
| 130 | MP0001853_heart_inflammation | 0.68314615 |
| 131 | MP0002277_abnormal_respiratory_mucosa | 0.67495153 |
| 132 | MP0005535_abnormal_body_temperature | 0.64780254 |
| 133 | MP0002009_preneoplasia | 0.64238718 |
| 134 | MP0008872_abnormal_physiological_respon | 0.59536949 |
| 135 | MP0005164_abnormal_response_to | 0.59206905 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.58676709 |
| 137 | MP0009642_abnormal_blood_homeostasis | 0.57101592 |
| 138 | MP0002006_tumorigenesis | 0.55642394 |
| 139 | MP0008873_increased_physiological_sensi | 0.54321358 |
| 140 | MP0003787_abnormal_imprinting | 0.53969874 |
| 141 | MP0003795_abnormal_bone_structure | 0.53368840 |
| 142 | MP0004484_altered_response_of | 0.51719349 |
| 143 | MP0005165_increased_susceptibility_to | 0.50872986 |
| 144 | MP0003045_fibrosis | 0.50137990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.16663284 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.08919114 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.64261632 |
| 4 | Abnormal platelet volume (HP:0011876) | 4.55031710 |
| 5 | Orchitis (HP:0100796) | 4.47981722 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.46956982 |
| 7 | Gingival bleeding (HP:0000225) | 4.46496953 |
| 8 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.46108772 |
| 9 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.40767842 |
| 10 | Purpura (HP:0000979) | 4.29650126 |
| 11 | Symptomatic seizures (HP:0011145) | 4.29542309 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.24253516 |
| 13 | Optic neuritis (HP:0100653) | 4.24253516 |
| 14 | Menorrhagia (HP:0000132) | 4.18079683 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.14773672 |
| 16 | Increased mean platelet volume (HP:0011877) | 4.04492336 |
| 17 | Encephalitis (HP:0002383) | 3.97746291 |
| 18 | Aplastic anemia (HP:0001915) | 3.95109981 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.92129539 |
| 20 | Obstructive lung disease (HP:0006536) | 3.80125522 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80125522 |
| 22 | Chronic otitis media (HP:0000389) | 3.79026831 |
| 23 | Hypothermia (HP:0002045) | 3.73608505 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.60803397 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 3.52267710 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.44877188 |
| 27 | Abnormal platelet function (HP:0011869) | 3.41302469 |
| 28 | Impaired platelet aggregation (HP:0003540) | 3.41302469 |
| 29 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.40007202 |
| 30 | Abnormal glycosylation (HP:0012345) | 3.31971480 |
| 31 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.31971480 |
| 32 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.31971480 |
| 33 | Abnormal protein glycosylation (HP:0012346) | 3.31971480 |
| 34 | Petechiae (HP:0000967) | 3.25236036 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22895644 |
| 36 | IgM deficiency (HP:0002850) | 3.21677497 |
| 37 | Recurrent skin infections (HP:0001581) | 3.19660128 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 3.19648593 |
| 39 | Granulocytopenia (HP:0001913) | 3.19409101 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 3.18967840 |
| 41 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.17691180 |
| 42 | Chest pain (HP:0100749) | 3.15034763 |
| 43 | Leukocytosis (HP:0001974) | 3.12876785 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 3.09794428 |
| 45 | Large for gestational age (HP:0001520) | 3.09326605 |
| 46 | Late onset (HP:0003584) | 3.08594311 |
| 47 | Increased IgE level (HP:0003212) | 3.08459579 |
| 48 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.07006185 |
| 49 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.07006185 |
| 50 | Vasculitis (HP:0002633) | 3.03500909 |
| 51 | Agammaglobulinemia (HP:0004432) | 2.97129731 |
| 52 | Decreased circulating renin level (HP:0003351) | 2.94142212 |
| 53 | Arterial thrombosis (HP:0004420) | 2.90722370 |
| 54 | Increased IgM level (HP:0003496) | 2.90558483 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.90457045 |
| 56 | Keratoconjunctivitis (HP:0001096) | 2.90379155 |
| 57 | Recurrent bronchitis (HP:0002837) | 2.90336850 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.89493473 |
| 59 | Progressive neurologic deterioration (HP:0002344) | 2.87899358 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.85994643 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.82918756 |
| 62 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.80701178 |
| 63 | Urticaria (HP:0001025) | 2.79457258 |
| 64 | Cellulitis (HP:0100658) | 2.78300379 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.76895105 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.76248772 |
| 67 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73514733 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.67893475 |
| 69 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.66743945 |
| 70 | Abnormality of T cells (HP:0002843) | 2.66551595 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.64199439 |
| 72 | Severe combined immunodeficiency (HP:0004430) | 2.62156569 |
| 73 | Hypochromic anemia (HP:0001931) | 2.60657961 |
| 74 | Pustule (HP:0200039) | 2.57139955 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.56481217 |
| 76 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56481217 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.55387267 |
| 78 | Pulmonary embolism (HP:0002204) | 2.52315807 |
| 79 | 11 pairs of ribs (HP:0000878) | 2.51765041 |
| 80 | Hemoptysis (HP:0002105) | 2.51014404 |
| 81 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.49852227 |
| 82 | Hypoplasia of the thymus (HP:0000778) | 2.49043155 |
| 83 | Eosinophilia (HP:0001880) | 2.48977290 |
| 84 | Panhypogammaglobulinemia (HP:0003139) | 2.48890680 |
| 85 | Reduced antithrombin III activity (HP:0001976) | 2.46734919 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 2.46012023 |
| 87 | T lymphocytopenia (HP:0005403) | 2.44107099 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43548119 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43548119 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43548119 |
| 91 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.43269657 |
| 92 | Thrombocytosis (HP:0001894) | 2.42928247 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.38969311 |
| 94 | Abnormality of eosinophils (HP:0001879) | 2.38499146 |
| 95 | Ketoacidosis (HP:0001993) | 2.36764542 |
| 96 | Increased serum ferritin (HP:0003281) | 2.33662858 |
| 97 | Gingivitis (HP:0000230) | 2.33270241 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 2.32011871 |
| 99 | Menstrual irregularities (HP:0000858) | 2.31532900 |
| 100 | Hyperlipoproteinemia (HP:0010980) | 2.31357472 |
| 101 | Vertigo (HP:0002321) | 2.30863938 |
| 102 | Abnormality of T cell number (HP:0011839) | 2.25983888 |
| 103 | Prominent metopic ridge (HP:0005487) | 2.25730357 |
| 104 | Acute hepatic failure (HP:0006554) | 2.25489284 |
| 105 | Bruising susceptibility (HP:0000978) | 2.25483722 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.25070663 |
| 107 | Agitation (HP:0000713) | 2.23786569 |
| 108 | Broad face (HP:0000283) | 2.22707332 |
| 109 | Neuroendocrine neoplasm (HP:0100634) | 2.22689914 |
| 110 | Microcytic anemia (HP:0001935) | 2.20282573 |
| 111 | Colitis (HP:0002583) | 2.20274238 |
| 112 | Recurrent viral infections (HP:0004429) | 2.20138543 |
| 113 | Recurrent fungal infections (HP:0002841) | 2.18514355 |
| 114 | Anorexia (HP:0002039) | 2.17814512 |
| 115 | Hyperglycemia (HP:0003074) | 2.17800061 |
| 116 | Retinal atrophy (HP:0001105) | 2.16863098 |
| 117 | Abnormality of the prostate (HP:0008775) | 2.15642755 |
| 118 | Myositis (HP:0100614) | 2.15534407 |
| 119 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.14856086 |
| 120 | Increased cerebral lipofuscin (HP:0011813) | 2.14476561 |
| 121 | Sepsis (HP:0100806) | 2.13595137 |
| 122 | Bronchitis (HP:0012387) | 2.11880169 |
| 123 | Joint swelling (HP:0001386) | 2.10370311 |
| 124 | Papilledema (HP:0001085) | 2.10347174 |
| 125 | Type II lissencephaly (HP:0007260) | 2.10295068 |
| 126 | Chronic sinusitis (HP:0011109) | 2.09057192 |
| 127 | Osteomyelitis (HP:0002754) | 2.08869983 |
| 128 | Nasal polyposis (HP:0100582) | 2.06844196 |
| 129 | Abnormality of the pleura (HP:0002103) | 2.06454270 |
| 130 | Stomach cancer (HP:0012126) | 2.05443004 |
| 131 | Abnormality of B cell number (HP:0010975) | 2.04807199 |
| 132 | Abnormal pupillary function (HP:0007686) | 2.03131961 |
| 133 | Epistaxis (HP:0000421) | 2.02570237 |
| 134 | IgG deficiency (HP:0004315) | 2.02010136 |
| 135 | Gangrene (HP:0100758) | 2.01106609 |
| 136 | Episodic fever (HP:0001954) | 1.98934322 |
| 137 | Patchy hypopigmentation of hair (HP:0011365) | 1.98577820 |
| 138 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.98384555 |
| 139 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.98384555 |
| 140 | Unilateral renal agenesis (HP:0000122) | 1.97815993 |
| 141 | Cortical visual impairment (HP:0100704) | 1.97627488 |
| 142 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.96223549 |
| 143 | Hypoplasia of the fovea (HP:0007750) | 1.96223549 |
| 144 | Thrombophlebitis (HP:0004418) | 1.94273463 |
| 145 | Autoimmune thrombocytopenia (HP:0001973) | 1.93705909 |
| 146 | Neutropenia (HP:0001875) | 1.93125605 |
| 147 | Amyloidosis (HP:0011034) | 1.92677031 |
| 148 | Abnormality of renin-angiotensin system (HP:0000847) | 1.92251033 |
| 149 | Limb hypertonia (HP:0002509) | 1.91283980 |
| 150 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.90998216 |
| 151 | Skin rash (HP:0000988) | 1.89916954 |
| 152 | Combined immunodeficiency (HP:0005387) | 1.88979964 |
| 153 | Glomerulopathy (HP:0100820) | 1.88087679 |
| 154 | Type 2 muscle fiber atrophy (HP:0003554) | 1.87558518 |
| 155 | Autoimmune hemolytic anemia (HP:0001890) | 1.86889097 |
| 156 | Hyperphosphatemia (HP:0002905) | 1.86821113 |
| 157 | Retinal dysplasia (HP:0007973) | 1.86602674 |
| 158 | Viral hepatitis (HP:0006562) | 1.85942397 |
| 159 | Spinal canal stenosis (HP:0003416) | 1.85010844 |
| 160 | Insulin resistance (HP:0000855) | 1.84530029 |
| 161 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.84145360 |
| 162 | Recurrent abscess formation (HP:0002722) | 1.82988488 |
| 163 | Abnormal number of erythroid precursors (HP:0012131) | 1.82263329 |
| 164 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81934569 |
| 165 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81934569 |
| 166 | Pheochromocytoma (HP:0002666) | 1.81609497 |
| 167 | Chronic diarrhea (HP:0002028) | 1.80290437 |
| 168 | White forelock (HP:0002211) | 1.80226081 |
| 169 | Abnormality of the nasal mucosa (HP:0000433) | 1.79328088 |
| 170 | Abnormality of dental color (HP:0011073) | 1.78482953 |
| 171 | Meningitis (HP:0001287) | 1.78423744 |
| 172 | Microvesicular hepatic steatosis (HP:0001414) | 1.77851262 |
| 173 | Lymphopenia (HP:0001888) | 1.77036590 |
| 174 | Hepatic necrosis (HP:0002605) | 1.76405738 |
| 175 | Abnormality of the metopic suture (HP:0005556) | 1.75081719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.69310843 |
| 2 | MAPK15 | 4.28597793 |
| 3 | INSRR | 4.14374674 |
| 4 | PASK | 3.89913192 |
| 5 | STK16 | 3.45606515 |
| 6 | TXK | 3.26743485 |
| 7 | GRK6 | 3.05545177 |
| 8 | MAP4K1 | 2.90731128 |
| 9 | TAOK3 | 2.68288027 |
| 10 | FLT3 | 2.65030269 |
| 11 | TNIK | 2.28788854 |
| 12 | HIPK2 | 2.24222757 |
| 13 | TEC | 2.21369972 |
| 14 | KIT | 2.19262553 |
| 15 | ZAP70 | 2.16341479 |
| 16 | WNK3 | 2.07244230 |
| 17 | BTK | 2.05744332 |
| 18 | JAK3 | 2.00951723 |
| 19 | PRPF4B | 1.77656794 |
| 20 | PIK3CG | 1.72592760 |
| 21 | MAP3K12 | 1.63638201 |
| 22 | SIK3 | 1.60763145 |
| 23 | ITK | 1.60288992 |
| 24 | NLK | 1.58262291 |
| 25 | MAP3K11 | 1.55788597 |
| 26 | MAPKAPK5 | 1.54179431 |
| 27 | CAMKK2 | 1.47631535 |
| 28 | IKBKE | 1.36751572 |
| 29 | SYK | 1.33035861 |
| 30 | ADRBK2 | 1.32969933 |
| 31 | EPHA3 | 1.30682518 |
| 32 | MUSK | 1.28266575 |
| 33 | NME2 | 1.28035929 |
| 34 | CDK19 | 1.24495139 |
| 35 | FGR | 1.21764490 |
| 36 | IRAK4 | 1.19776553 |
| 37 | UHMK1 | 1.18612144 |
| 38 | TBK1 | 1.12210733 |
| 39 | SCYL2 | 1.11725331 |
| 40 | BMX | 1.10974508 |
| 41 | MAP3K3 | 1.09451242 |
| 42 | LCK | 1.08157666 |
| 43 | TAOK1 | 1.00395177 |
| 44 | IRAK1 | 0.98469788 |
| 45 | VRK1 | 0.98189057 |
| 46 | IRAK3 | 0.97636297 |
| 47 | PRKCQ | 0.97520233 |
| 48 | PTK2B | 0.96758551 |
| 49 | WNK4 | 0.95307486 |
| 50 | EPHB1 | 0.95158058 |
| 51 | DYRK3 | 0.95073347 |
| 52 | FGFR4 | 0.94981577 |
| 53 | MAP3K13 | 0.92600852 |
| 54 | TYK2 | 0.91557224 |
| 55 | BRSK2 | 0.91387091 |
| 56 | KDR | 0.90996388 |
| 57 | PIM2 | 0.90750764 |
| 58 | PDK1 | 0.89177244 |
| 59 | CDK8 | 0.89148352 |
| 60 | SIK2 | 0.88659931 |
| 61 | STK10 | 0.84147310 |
| 62 | MAP3K1 | 0.81462447 |
| 63 | LYN | 0.79568240 |
| 64 | MAPK12 | 0.78863749 |
| 65 | MAPKAPK3 | 0.76874936 |
| 66 | JAK1 | 0.76616198 |
| 67 | TESK2 | 0.76598059 |
| 68 | TLK1 | 0.76211596 |
| 69 | TGFBR1 | 0.75375806 |
| 70 | PIM1 | 0.74437599 |
| 71 | BLK | 0.73750249 |
| 72 | MATK | 0.71504771 |
| 73 | DAPK2 | 0.71045723 |
| 74 | EIF2AK3 | 0.70141617 |
| 75 | BMPR1B | 0.69512798 |
| 76 | EEF2K | 0.68686062 |
| 77 | TAOK2 | 0.68390585 |
| 78 | IKBKB | 0.67781660 |
| 79 | PRKG2 | 0.67734805 |
| 80 | MAP4K2 | 0.66027827 |
| 81 | FYN | 0.65998292 |
| 82 | PRKD2 | 0.65906213 |
| 83 | LRRK2 | 0.65341951 |
| 84 | PRKCH | 0.64676067 |
| 85 | MARK2 | 0.64311706 |
| 86 | MAP2K7 | 0.62327940 |
| 87 | PDPK1 | 0.59725349 |
| 88 | GRK5 | 0.59022900 |
| 89 | RPS6KA5 | 0.57829840 |
| 90 | FES | 0.57314633 |
| 91 | TIE1 | 0.56866729 |
| 92 | BCKDK | 0.56443700 |
| 93 | YES1 | 0.55376063 |
| 94 | CSF1R | 0.54943708 |
| 95 | CSK | 0.53740202 |
| 96 | CAMKK1 | 0.52345683 |
| 97 | MARK3 | 0.51284544 |
| 98 | IRAK2 | 0.49809913 |
| 99 | MAP2K3 | 0.48826999 |
| 100 | JAK2 | 0.47891561 |
| 101 | MAP3K7 | 0.46572292 |
| 102 | DYRK1B | 0.46160596 |
| 103 | MAP3K14 | 0.45978371 |
| 104 | DAPK1 | 0.44202954 |
| 105 | HCK | 0.43298582 |
| 106 | RET | 0.43064590 |
| 107 | ERN1 | 0.41693298 |
| 108 | MAP3K6 | 0.41659348 |
| 109 | MAPK7 | 0.41470937 |
| 110 | MAP3K5 | 0.41153088 |
| 111 | TNK2 | 0.40878444 |
| 112 | MAP2K2 | 0.39748939 |
| 113 | CAMK1 | 0.39593651 |
| 114 | MAP3K2 | 0.39275772 |
| 115 | CHUK | 0.35783331 |
| 116 | NEK6 | 0.35527814 |
| 117 | MAPK11 | 0.34396298 |
| 118 | PRKCD | 0.34265982 |
| 119 | MAPK3 | 0.33986360 |
| 120 | MAP2K6 | 0.33224796 |
| 121 | MAPK13 | 0.33125229 |
| 122 | PRKD3 | 0.32889642 |
| 123 | BMPR2 | 0.32884390 |
| 124 | FRK | 0.32182173 |
| 125 | PRKD1 | 0.31383150 |
| 126 | MAPKAPK2 | 0.31375527 |
| 127 | STK11 | 0.30323435 |
| 128 | FGFR3 | 0.30035393 |
| 129 | TGFBR2 | 0.29950017 |
| 130 | RPS6KA6 | 0.29878930 |
| 131 | CDK4 | 0.28013823 |
| 132 | ADRBK1 | 0.27889572 |
| 133 | ACVR1B | 0.27859927 |
| 134 | NUAK1 | 0.27280603 |
| 135 | RPS6KL1 | 0.26802811 |
| 136 | RPS6KC1 | 0.26802811 |
| 137 | ABL1 | 0.26781226 |
| 138 | IGF1R | 0.26321286 |
| 139 | MAP2K4 | 0.26233634 |
| 140 | RPS6KB1 | 0.25775641 |
| 141 | CLK1 | 0.25721642 |
| 142 | WNK1 | 0.25169533 |
| 143 | KSR2 | 0.22926824 |
| 144 | RAF1 | 0.20359459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.67012700 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.26246295 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.79883752 |
| 4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.54964806 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33169554 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.08673267 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.01891303 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99189489 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 1.87064026 |
| 10 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.84854649 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.77038887 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.70793619 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65058034 |
| 14 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.63853977 |
| 15 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.63687140 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55743527 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.54547859 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.54139965 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50949030 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50384037 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45902967 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45663632 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.39199152 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.34107593 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30936169 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26878045 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26770688 |
| 28 | Lysosome_Homo sapiens_hsa04142 | 1.26025404 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24884579 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22261550 |
| 31 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.19415153 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18136601 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17063414 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13343460 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.10143316 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09745919 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06794381 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05681959 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03754855 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02768817 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.01419415 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00286482 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 0.97059208 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96904252 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96604068 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92560935 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91214276 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90287923 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 0.90078306 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.88964194 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88246050 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87525504 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.87465697 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86563002 |
| 55 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86147273 |
| 56 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85704409 |
| 57 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84531418 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84331485 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81089285 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.80864874 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 0.80564442 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79710956 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.79470256 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77800902 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76747813 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75835951 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75765467 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75601873 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75014974 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74660196 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74575454 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73378828 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.73313322 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73280026 |
| 75 | RNA polymerase_Homo sapiens_hsa03020 | 0.72872160 |
| 76 | DNA replication_Homo sapiens_hsa03030 | 0.72534638 |
| 77 | Mismatch repair_Homo sapiens_hsa03430 | 0.71768792 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71296510 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.71241206 |
| 80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71199618 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69944529 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68103888 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68077943 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.67245085 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67208222 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65872369 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64334048 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64178724 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60732935 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60633764 |
| 91 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60211839 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.58845680 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.58616166 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58478787 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58266893 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57757424 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57663468 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57523434 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56032473 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55921020 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55817847 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.55071582 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53414896 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51819892 |
| 105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50315066 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49696025 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48067512 |
| 108 | Spliceosome_Homo sapiens_hsa03040 | 0.47828893 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.47812744 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46883976 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46657142 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.46395570 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44564132 |
| 114 | Base excision repair_Homo sapiens_hsa03410 | 0.44049970 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.43200553 |
| 116 | Olfactory transduction_Homo sapiens_hsa04740 | 0.42552378 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42242891 |
| 118 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40893892 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40762776 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40327052 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40211272 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37951815 |
| 123 | Proteasome_Homo sapiens_hsa03050 | 0.37436274 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.37305038 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36702312 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36155074 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34855796 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.34835032 |
| 129 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.34047255 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34027240 |
| 131 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33926895 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33466923 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33076871 |
| 134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32288985 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31886700 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.31563497 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31217991 |
| 138 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30148571 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29473196 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.29288523 |
| 141 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29167321 |
| 142 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29014570 |
| 143 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27696885 |
| 144 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27608514 |
| 145 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27169285 |
| 146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25560715 |
| 147 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25500790 |

